Follicular Thyroid Cancer

Follicular Thyroid Cancer is a type of thyroid cancer that originates from the follicular cells of the thyroid gland. Understanding this condition is crucial for early detection and effective management.

Follicular Thyroid Cancer

Key Takeaways

  • Follicular Thyroid Cancer is the second most common type of differentiated thyroid cancer, accounting for 10-15% of all thyroid cancers.
  • It often presents as a palpable neck lump and is definitively diagnosed through surgical biopsy, as fine needle aspiration (FNA) cannot distinguish it from benign adenomas.
  • Primary treatment involves surgery, often followed by radioactive iodine therapy to eliminate residual cancer cells.
  • The prognosis for follicular thyroid cancer is generally favorable, especially when detected early and localized.
  • Long-term follow-up is essential to monitor for recurrence and manage thyroid hormone levels.

What is Follicular Thyroid Cancer?

Follicular Thyroid Cancer refers to a malignancy that develops from the follicular cells of the thyroid gland, which are responsible for producing thyroid hormones. It is the second most common form of differentiated thyroid cancer, following papillary thyroid cancer, and accounts for approximately 10-15% of all thyroid cancer diagnoses. Unlike papillary thyroid cancer, which often spreads through the lymphatic system, follicular thyroid cancer typically spreads through the bloodstream to distant sites such as the lungs, bones, and brain, though this is less common in early stages.

This type of cancer is more prevalent in older individuals and women. While the exact cause is often unknown, risk factors can include a history of radiation exposure to the head and neck, and certain genetic syndromes. According to the American Cancer Society, the overall incidence of thyroid cancer has been rising, with follicular thyroid cancer remaining a significant subtype requiring specific diagnostic and treatment approaches.

Symptoms and Diagnosis of Follicular Thyroid Cancer

The early stages of follicular thyroid cancer symptoms are often subtle or absent, making early detection challenging. The most common symptom is the presence of a painless lump or nodule in the neck, which may be discovered during a routine physical examination or by the individual themselves. Less common symptoms, which may indicate more advanced disease, include hoarseness, difficulty swallowing, persistent cough, or neck pain.

Diagnosis typically begins with a physical examination of the neck and an ultrasound to visualize the thyroid gland and any suspicious nodules. Blood tests to measure thyroid-stimulating hormone (TSH) levels are also performed, although thyroid function is often normal in patients with follicular thyroid cancer. A fine needle aspiration (FNA) biopsy is a common diagnostic tool for thyroid nodules; however, for follicular lesions, FNA cannot definitively distinguish between a benign follicular adenoma and a malignant follicular carcinoma. Therefore, a definitive diagnosis often requires surgical removal of the suspicious nodule or thyroid lobe for pathological examination, such as a lobectomy or total thyroidectomy.

Follicular Thyroid Cancer Treatment and Prognosis

The primary approach for follicular thyroid cancer treatment options is surgery. This typically involves a total thyroidectomy, which is the complete removal of the thyroid gland, or a lobectomy, which is the removal of the affected lobe. Following surgery, many patients undergo radioactive iodine (RAI) therapy. This treatment targets and destroys any remaining thyroid tissue, including microscopic cancer cells that may have spread beyond the thyroid gland, thereby reducing the risk of recurrence. Patients who undergo a total thyroidectomy will require lifelong thyroid hormone replacement therapy to compensate for the removed gland.

The follicular thyroid cancer prognosis is generally favorable, especially for patients whose cancer is localized at the time of diagnosis. Factors influencing prognosis include the patient’s age, tumor size, extent of invasion into surrounding tissues, and the presence of distant metastases. For localized follicular thyroid cancer, the 5-year survival rate is very high, often exceeding 95%, as reported by the National Cancer Institute’s SEER program. Regular follow-up appointments, including physical exams, neck ultrasounds, and blood tests (such as thyroglobulin levels), are crucial for monitoring for any signs of recurrence. While rare, external beam radiation therapy or chemotherapy may be considered for aggressive or advanced cases that do not respond to standard treatments.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.